Similar articles

• [Osteomalacia and anticonvulsant therapy: serum assay of 25 hydroxy D in an epileptic population (author's transl) (proceedings)].

  Ribot C, Geraud G, Castignol M, Dero M, Geraud J, Boulard C. Ribot C, et al. Ann Endocrinol (Paris). 1976 Nov-Dec;37(6):483-4. Ann Endocrinol (Paris). 1976. PMID: 1026169 French. No abstract available.
• Calcium metabolism during anticonvulsant therapy.

  Snehalata C, Ramamurthi B. Snehalata C, et al. Neurol India. 1972 Jun;20(2):94-8. Neurol India. 1972. PMID: 4635585 No abstract available.
• [Long-term effects of anti-epileptic treatment on the blood calcium, phosphates and alkaline phosphatase].

  Gasparoni MC, Martini C, Garibaldi E, Colombo A. Gasparoni MC, et al. Minerva Pediatr. 1977 Jun 16;29(21):1373-7. Minerva Pediatr. 1977. PMID: 882080 Italian. No abstract available.
• [Bone diseases due to long-term administration of anticonvulsants during the age of growth].

  Parnitzke C, Dürrschmidt V. Parnitzke C, et al. Z Gesamte Inn Med. 1979 Sep 1;34(17):471-6. Z Gesamte Inn Med. 1979. PMID: 395779 Review. German.
• Osteomalacia and anticonvulsant drugs.

  [No authors listed] [No authors listed] Nutr Rev. 1971 Feb;29(2):38-41. doi: 10.1111/j.1753-4887.1971.tb07232.x. Nutr Rev. 1971. PMID: 4938575 Review. No abstract available.